Hepatocellular carcinoma in Child-Pugh C cirrhosis: Prognostic factors and survival benefit of nontransplant treatments

Digestive Diseases

Volumn 31, Issue 5-6, 2013, Pages 490-498

  Kudo, Masatoshi ^a   Osaki, Yukio ^b   Matsunaga, Takashi ^c   Kasugai, Hiroshi ^d   Oka, Hiroko ^e   Seki, Toshihito ^f  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA RED CROSS HOSPITAL   (Japan)

^c Department of Medical Informatics ^*  (Japan)

^d OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^e OSAKA CITY GENERAL HOSPITAL   (Japan)

^f KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Child Pugh C cirrhosis; Hepatocellular carcinoma; Nontransplant treatment

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN;

BRAIN DISEASE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; COMORBIDITY; CONFERENCE PAPER; EPIDEMIOLOGY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; PROTHROMBIN TIME; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL RATE; ARTICLE; ASCITES; CANCER STAGING; CHILD PUGH C CIRRHOSIS; CONTROLLED STUDY; HEPATIC ARTERIAL INFUSION CHEMOTHERAPY; HEPATITIS B VIRUS; MULTICENTER STUDY;

CARCINOMA, HEPATOCELLULAR; HUMANS; JAPAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR BURDEN;

EID: 84890051939     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000355259     Document Type: Conference Paper

References (15)

1. Kudo M, Chung H, Osaki Y: Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003; 38: 207-215.
2. Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T: Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 2004; 40: 1396-1405.
3. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
4. Bruix J, Sherman M: Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
5. Llovet JM, Ducreux M: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943.
6. Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, et al: Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-474.
7. Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, Matsuyama Y, Okazaki M, Okita K, Omata M, et al: Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 2008; 38: 37-51.
8. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
9. Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M: Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2011; 29: 339-364.
10. Belghiti J, Fuks D: Liver resection and transplantation in hepatocellular carcinoma. Liver Cancer 2012; 1: 71-82.
11. Lencioni R: Chemoembolization in patients with hepatocellular carcinoma. Liver Cancer 2012; 1: 41-50.
12. Lin S, Hoffmann K, Schemmer P: Treatment of hepatocellular carcinoma: a systematic review. Liver Cancer 2012; 1: 144-158.
13. Lin SM: Local ablation for hepatocellular carcinoma in Taiwan. Liver Cancer 2013; 2: 73-83.
14. Kudo M: Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy. Liver Cancer 2012; 1: 62-70.
15. Nouso K, Ito Y, Kuwaki K, Kobayashi Y, Nakamura S, Ohashi Y, Yamamoto K: Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis. Br J Cancer 2008; 98: 1161-1165.